tiprankstipranks
Trending News
More News >
Initiator Pharma A/S (SE:INIT)
:INIT
Sweden Market

Initiator Pharma A/S (INIT) Income Statement

Compare
0 Followers

Initiator Pharma A/S Income Statement

Last quarter (Q4 2025), Initiator Pharma A/S's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, Initiator Pharma A/S's net income was kr-2.95M. See Initiator Pharma A/S’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profit
kr -14.83Mkr -11.07Kkr -23.41Kkr -38.42Kkr -21.63K
Operating Expenses
kr 2.95Mkr 3.43Kkr 3.62Kkr 3.31Kkr 1.45K
Depreciation and Amortization
kr 0.00kr 0.00kr 0.00kr 11.00kr 11.00
EBITDA
kr -18.20Mkr -14.50Kkr -27.03Kkr -41.73Kkr -23.06K
Operating Income
kr -18.20Mkr -14.50Kkr -27.03Kkr -41.74Kkr -23.07K
Other Income/Expenses
kr 1.11Mkr -334.00kr -677.00kr -2.39Kkr -1.17K
Pretax Income
kr -17.09Mkr -14.84Kkr -27.71Kkr -44.13Kkr -24.24K
Net Income
kr -14.01Mkr -12.93Kkr -22.87Kkr -38.45Mkr -21.06M
Per Share Metrics
Basic EPS
kr -0.23kr -0.23kr 0.00kr -0.80kr -0.60
Diluted EPS
kr -0.23kr -0.23kr 0.00kr -0.80kr -0.60
Weighted Average Shares Outstanding
62.30M 55.62K 52.42M 48.33K 35.09K
Weighted Average Shares Outstanding (Diluted)
62.30M 57.27K 52.42M 48.33K 35.09K
Currency in DKK

Initiator Pharma A/S Earnings and Revenue History